Heron Therapeutics (HRTX) Current Leases (2019 - 2026)
Heron Therapeutics' (HRTX) quarterly Current Leases came in at $780000.0 in Q3 2025, down 75.99% YoY from $3.2 million in Q3 2024, and down 49.32% on a QoQ basis from $1.5 million in Q2 2025.
Heron Therapeutics (HRTX) Current Leases (2019 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 7 years of Current Leases data on file, last reported at $780000.0 in Q3 2025.
- Quarterly Current Leases fell 75.99% year-over-year to $780000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $780000.0 (down 75.99% YoY) and the FY2024 annual result came in at $3.0 million, down 1.24% from the prior year.
- Current Leases slipped to $780000.0 in Q3 2025, from $1.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.3 million in Q3 2021 to a low of $780000.0 in Q3 2025.
- A 5-year average of $2.7 million and a median of $2.8 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases advanced 23.8% — and 2025, when it plunged 75.99%.
- Tracing HRTX's Current Leases over 5 years: stood at $2.4 million in 2021, then increased by 11.46% to $2.7 million in 2022, then advanced by 14.14% to $3.1 million in 2023, then retreated by 1.24% to $3.0 million in 2024, then tumbled by 74.32% to $780000.0 in 2025.
- The last three Current Leases figures came in at $780000.0 (Q3 2025), $1.5 million (Q2 2025), and $2.3 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 200,000.00 |
| Sep 30, 2025 | 780,000.00 |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 2.58 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.55 Mn |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 2.42 Mn |
| Sep 30, 2021 | 3.25 Mn |
| Jun 30, 2021 | 3.16 Mn |
| Mar 31, 2021 | 3.08 Mn |